Welcome to Pharmaceutical Discussion Group - PhDG
an egalitarian 'speak-out' lounge for all pharmaceutical professionals & public health stakeholders' world over...
This group consists of:
1167
Group
Members
you can
connect with
62
Discussions
you can
join
15
Member
Objectives
you can
assist with
Upcoming Events
(This area will display upcoming events as they approach on the calendar)
Ad: Create a site like this for other groups you're involved with. Signup Free »
New and Notable Discussions
 Join Networks and Groups
|
by Steven 2 days ago | 1 post |
|
Design of Experiments
|
by Neal 2 days ago | 5 posts |
|
Stability program as per ICH gu...
Stability program as per ICH guide lines |
by Narayanappa 9 days ago | 11 posts |
|
Portfolio Assessment Models
|
by Robert 14 days ago | 3 posts |
|
EU to fund "pre-competitive wor...
EU to fund "pre-competitive work" of drug discovery |
by Viswanatha 04/30/2008 | 1 post |
|
Inorganic Impurities: Heavy Met...
Inorganic Impurities: Heavy Metals – Proposed USP General Chapter |
by Viswanatha 04/25/2008 | 3 posts |
|
Heparin Issue: Warning sign for...
Heparin Issue: Warning sign for other Macromolecules?? |
by Viswanatha 04/24/2008 | 1 post |
|
Post-market surveillance
|
by Siva 04/24/2008 | 5 posts |
|
Translational Medicine Forum on...
Translational Medicine Forum on PhDG |
by Viswanatha 04/22/2008 | 2 posts |
|
Success rate of pharmaceutical ...
Success rate of pharmaceutical development |
by Tatsuzo 04/09/2008 | 5 posts |
Headlines and Links
Source: FDA Center for Drug Evaluation and Research - What's New
FDA approves new Medication Guide and Label for Varenicline (marketed as Chantix)
FDA approves new Medication Guide and Label for Varenicline (marketed as Chantix)
rate this
Source: FDA Center for Drug Evaluation and Research - What's NewPublished: about 12 hours ago
Source: Reuters: Health News
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
WASHINGTON (Reuters) - An experimental drug from Swiss drugmaker Novartis slowed the progression of kidney cancer in patients whose tumors returned after initial chemotherapy, researchers reported on Friday.
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
WASHINGTON (Reuters) - An experimental drug from Swiss drugmaker Novartis slowed the progression of kidney cancer in patients whose tumors returned after initial chemotherapy, researchers reported on Friday.
rate this
Source: Reuters: Health NewsPublished: about 12 hours ago
Source: Reuters: Health News
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
WASHINGTON (Reuters) - U.S. health officials issued an alert on Friday about the risk of first-trimester miscarriages and birth defects from Novartis AG and Roche Holding AG transplant drugs.
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
WASHINGTON (Reuters) - U.S. health officials issued an alert on Friday about the risk of first-trimester miscarriages and birth defects from Novartis AG and Roche Holding AG transplant drugs.
rate this
Source: Reuters: Health NewsPublished: about 14 hours ago
Source: Reuters: Health News
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
NEW YORK (Reuters Health) - Anorexic women with a history of childhood anxiety may have particularly severe symptoms of the eating disorder, a study suggests.
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
NEW YORK (Reuters Health) - Anorexic women with a history of childhood anxiety may have particularly severe symptoms of the eating disorder, a study suggests.
rate this
Source: Reuters: Health NewsPublished: about 15 hours ago
Source: Reuters: Health News
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
NEW YORK (Reuters Health) - Just 5 percent of U.S. cancer survivors are meeting experts' recommendations on diet, physical activity and cigarette smoking, a new survey shows.
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
NEW YORK (Reuters Health) - Just 5 percent of U.S. cancer survivors are meeting experts' recommendations on diet, physical activity and cigarette smoking, a new survey shows.
rate this
Source: Reuters: Health NewsPublished: about 16 hours ago
Source: Reuters: Health News
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
OTTAWA (Reuters) - Canada said on Friday it was scrapping a nuclear reactor project designed to produce medical radioisotopes, a move that means half the world's supply will be made by a 50-year-old reactor that was temporarily shut down for safety reasons last year.
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
OTTAWA (Reuters) - Canada said on Friday it was scrapping a nuclear reactor project designed to produce medical radioisotopes, a move that means half the world's supply will be made by a 50-year-old reactor that was temporarily shut down for safety reasons last year.
rate this
Source: Reuters: Health NewsPublished: about 16 hours ago
Recent Group Activity
Re: Stability program as per ICH guide lines
New Reply posted by Jim
about 21 hours ago
Jim said: "T.R., I would be happy to provide input. Have you already determined the temperature monitoring type and data capture frequency? Regard...
Re: Stability program as per ICH guide lines
New Reply posted by Narayanappa
1 day ago
Narayanappa said: "Thank you Jim for your reply, Yes I am looking for both temperature sensitive products as well as the products stored at RT. The purpose...
Re: Stability program as per ICH guide lines
New Reply posted by Jim
1 day ago
Jim said: "Are you refering to cold chain stability for temperature-sensitive drugs such as vaccines? If so, I have done cold chain studies both domes...
